Approval · Notice of Compliance 38100 · 2026
QOSEQU: Notice of Compliance 38100
Issued August 12, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38100
- Date
- August 12, 2026
- Company
- Mantra Pharma Inc.Brossard, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- PROLIA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QOSEQU | 02570750 | Approved |
Medicinal ingredients
- DENOSUMAB 60 MG per ML